ProShares Ultra Nasdaq Biotechnology (BIB)

NASDAQ: BIB · IEX Real-Time Price · USD
58.42
+0.33 (0.56%)
Mar 28, 2024, 9:31 AM EDT - Market open
0.56%
Assets $94.43M
Expense Ratio 0.95%
PE Ratio n/a
Shares Out 1.68M
Dividend (ttm) $0.08
Dividend Yield 0.13%
Ex-Dividend Date Mar 20, 2024
Payout Ratio n/a
1-Year Return +11.39%
Volume 3,563
Open 58.19
Previous Close 58.09
Day's Range 58.19 - 58.42
52-Week Low 40.10
52-Week High 62.45
Beta 1.52
Holdings 229
Inception Date Apr 8, 2010

About BIB

Fund Home Page

The ProShares Ultra Nasdaq Biotechnology (BIB) is an exchange-traded fund that is based on the NASDAQ / Biotechnology index. The fund provides 2x daily exposure to a modified market-cap-weighted index of biotechnology and pharmaceutical companies listed on NASDAQ. BIB was launched on Apr 8, 2010 and is issued by ProShares.

Asset Class Equity
Category Trading--Leveraged Equity
Stock Exchange NASDAQ
Ticker Symbol BIB
ETF Provider ProShares
Index Tracked NASDAQ / Biotechnology

Top 10 Holdings

149.53% of assets
Name Symbol Weight
NASDAQ BIO INDEX SWAP BNP n/a 52.87%
NASDAQ BIOTECHNOLOGY INDEX SWAP SOCIETE GENERALE n/a 23.98%
NASDAQ BIOTECHNOLOGY INDEX SWAP UBS AG n/a 22.77%
NASDAQ BIOTECHNOLOGY INDEX SWAP BANK OF AMERICA NA n/a 15.49%
NASDAQ BIOTECHNOLOGY INDEX SWAP GOLDMAN SACHS INTERNATIONAL n/a 6.14%
Amgen Inc. AMGN 5.99%
Gilead Sciences, Inc. GILD 5.85%
Regeneron Pharmaceuticals, Inc. REGN 5.81%
Vertex Pharmaceuticals Incorporated VRTX 5.79%
NASDAQ BIOTECHNOLOGY INDEX SWAP CITIBANK NA n/a 4.84%
View More Holdings

Dividends

Ex-Dividend Amount Pay Date
Mar 20, 2024 $0.04032 Mar 27, 2024
Dec 20, 2023 $0.03839 Dec 28, 2023
Dec 22, 2022 $0.01985 Dec 30, 2022
Sep 21, 2010 $0.011 Sep 28, 2010
Full Dividend History

News

There is no news available yet.